AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

IONIS PHARMACEUTICALS INC Director's Dealing 2018

Sep 24, 2018

30591_dirs_2018-09-24_d54cbe62-aca1-47ba-827a-fb6b72bd9407.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2018-09-23

Reporting Person: Reikes Peter N (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No Securities Owned	0	Direct